Balter Invenomic Fund Last Dividend Paid
| BIVIX Fund | USD 17.53 0.18 1.04% |
Balter Invenomic Fund fundamentals help investors to digest information that contributes to Balter Invenomic's financial success or failures. It also enables traders to predict the movement of Balter Mutual Fund. The fundamental analysis module provides a way to measure Balter Invenomic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Balter Invenomic mutual fund.
Balter |
Balter Invenomic Fund Mutual Fund Last Dividend Paid Analysis
Balter Invenomic's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Current Balter Invenomic Last Dividend Paid | 0.01 |
Most of Balter Invenomic's fundamental indicators, such as Last Dividend Paid, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Balter Invenomic Fund is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Balter Invenomic Fund has a Last Dividend Paid of 0.01. This is much higher than that of the Invenomic family and significantly higher than that of the Long-Short Equity category. The last dividend paid for all United States funds is notably lower than that of the firm.
Balter Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Balter Invenomic's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Balter Invenomic could also be used in its relative valuation, which is a method of valuing Balter Invenomic by comparing valuation metrics of similar companies.Balter Invenomic is currently under evaluation in last dividend paid among similar funds.
Fund Asset Allocation for Balter Invenomic
The fund invests most of its assets under management in cash or cash equivalents, with the rest of investments concentrated in stocks.Asset allocation divides Balter Invenomic's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Balter Fundamentals
| Total Asset | 901.55 M | ||||
| Annual Yield | 0.03 % | ||||
| Year To Date Return | 1.77 % | ||||
| One Year Return | (10.82) % | ||||
| Three Year Return | 18.94 % | ||||
| Five Year Return | 23.12 % | ||||
| Net Asset | 1.4 B | ||||
| Last Dividend Paid | 0.01 | ||||
| Cash Position Weight | 70.47 % | ||||
| Equity Positions Weight | 29.55 % |
About Balter Invenomic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Balter Invenomic Fund's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Balter Invenomic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Balter Invenomic Fund based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |